EichorEICHOR
Condition: Thoracic Neoplasms Lung Diseases Small Cell Lung Carcinoma Synced from ClinicalTrials.gov · August 07, 2026

Recruiting studies: Thoracic Neoplasms Lung Diseases Small Cell Lung Carcinoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Carbon Ion Therapy for Peripheral Non-small Cell Lung Cancer
Phase 2 · 1 location(s) · Shanghai Proton and Heavy Ion Center · NCT05613452Vortioxetine for Cognitive Function in ALK-positive NSCLC Treated With Lorlatinib
Phase N/A · 1 location(s) · Centro de Tratamiento e Investigación sobre Cáncer, Luis Car · NCT07633626Neoadjuvant Osimertinib + Chemotherapy for EGFR-mutant Stage III NSCLC
Phase 2 · 1 location(s) · Sun Yat-sen University · NCT05011487A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
Phase 1 · 8 location(s) · Erasca, Inc. · NCT06983743KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used W
Phase 1/Phase 2 · 46 location(s) · Merck Sharp & Dohme LLC · NCT04165070Observation on the Therapeutic Effect of Huaier Granules in the Adjuvant Treatment of Non-small Cell Lung Cancer After R
Phase N/A · 1 location(s) · Liaoning Cancer Hospital & Institute · NCT06109454Study of JYP0015 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Phase 2 · 1 location(s) · Guangzhou JOYO Pharma Co., Ltd · NCT06895031ICI Rechallenge for Advanced NSCLC With Long-Term Response to First-Line ICI
Phase 2 · 1 location(s) · Peking Union Medical College Hospital · NCT06388031A Study of JNJ-86974680 in Participants With Advanced Non-small Cell Lung Cancer
Phase 1 · 15 location(s) · Johnson & Johnson Enterprise Innovation Inc. · NCT06116786Electro-Acupuncture in Lung cancER : EALER Study
NA · 3 location(s) · Guangzhou University of Traditional Chinese Medicine · NCT07337096Irinotecan Liposome Combined With Anlotinib as Second-line Regimen for SCLC
NA · 1 location(s) · Fudan University · NCT06258642A Study to Evaluate the Efficacy and Safety of Glumetinib Combined With Osimertinib Mesylate Versus Platinum-based Doubl
Phase 3 · 1 location(s) · Shanghai JMT-Bio Inc. · NCT06829459A Study of BL-B01D1 in Combination With Osimertinib Mesylate Tablets in Patients With Locally Advanced or Metastatic Non
Phase 2 · 1 location(s) · Sichuan Baili Pharmaceutical Co., Ltd. · NCT06498986Neoadjuvant Therapy With Ensartinib Combined With Chemotherapy for ALK-positive Non - Small Cell Lung Cancer (NSCLC)
Phase 1/Phase 2 · 1 location(s) · Tang-Du Hospital · NCT07354061AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors
Phase 1 · 3 location(s) · Avacta Life Sciences Ltd · NCT07454642A Real-World Study Evaluating the Efficacy and Safety of Adebrelimab in Patients With Advanced SCLC
Phase N/A · 1 location(s) · Shanghai General Hospital, Shanghai Jiao Tong University Sch · NCT07434518Survey of Brigatinib Used To Treat People With Non-Small Cell Lung Cancer
Phase N/A · 1 location(s) · Takeda · NCT05100069Development and Dissemination of Exercise Prescription and Intervention for Cancer Populations
NA · 1 location(s) · Kaohsiung Medical University Chung-Ho Memorial Hospital · NCT07751783This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in
Phase 3 · 372 location(s) · Pfizer · NCT06758401Study of XB010 in Subjects With Solid Tumors
Phase 1 · 20 location(s) · Exelixis · NCT06545331Perioperative Tislelizumab for Resectable II-IIIB(N2) KRAS-mutated Nonsquamous Non-small Cell Lung Cancer
Phase 2 · 1 location(s) · Shanghai Chest Hospital · NCT06659042A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer
Phase 1/Phase 2 · 13 location(s) · IDEAYA Biosciences · NCT07174583An Exploratory Study of QL1706 Plus Chemotherapy in Perioperative NSCLC
NA · 1 location(s) · Peking Union Medical College Hospital · NCT07452003Efficacy of Neoadjuvant Immunotherapy in Patients With Lung Cancer
Phase N/A · 1 location(s) · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT07166003Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C
Phase 3 · 477 location(s) · NRG Oncology · NCT05624996A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
Phase 1 · 62 location(s) · Seagen, a wholly owned subsidiary of Pfizer · NCT05208762Microwave Ablation Plus Tislelizumab and Docetaxel in Advanced NSCLC After First-Line Immunotherapy Failure
Phase 2 · 1 location(s) · Tianjin Medical University Cancer Institute and Hospital · NCT07528274High-dose Furmonertinib or Combined With Chemotherapy in EGFR-mutant Advanced NSCLC After Disease Progression on Third-g
Phase 2 · 1 location(s) · Jialei Wang · NCT06652048Electroacupuncture Combined With Immune Checkpoint Inhibitors as Adjuvant Therapy After Surgery for Early-stage Non-smal
Phase 2/Phase 3 · 1 location(s) · Kong Fanming · NCT07034326ALG-LungCancerRegistry (SAFRO2202)
Phase N/A · 21 location(s) · Société Algérienne de Formation et de Recherche en Oncologie · NCT07161882
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.